Statistics
Publications
16
Citations
2.8K
H-Index
13
Active since
2008
Paul Burgess is an author at Novartis (Switzerland) specializing in medicine, oncology, and pharmacology.
Publications per year
2008–2024
16
16
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
Caroline Robert, Jean‐Jacques Grob, Daniil Stroyakovskiy et al. · New England Journal of Medicine · 2019 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 16